GlobeNewswire - Earnings Releases And Operating ResultsContains the last 20 releasesuuid:68f3e36d-1e97-4a50-8e34-f3331b1a26c2;id=77092021-03-02T14:15:00Znewsdesk@globenewswire.com (NewsDesk)http://www.yebxqs.cn/LegacyRss?Length=4newsdesk@globenewswire.comhttp://www.yebxqs.cn/news-release/2021/03/02/2185451/0/en/Hovnanian-Enterprises-Reports-Fiscal-2021-First-Quarter-Results.htmlHovnanian Enterprises Reports Fiscal 2021 First Quarter Results2021-03-02T14:15:00Z2021-03-02T16:58:40Z$27 Million Year-over-Year Improvement in Pretax Income First Quarter Gross Margin Percentage Increased 440 Basis Points Year-over-Year 85% Year-over-Year Increase in Consolidated Backlog Dollars to $1.67 Billion 51% Year-over-Year Increase in Land and Land Development Spend]]>2185451enGlobeNewswire Inc.Hovnanian Enterprises, Inc.Tue, 02 Mar 2021 14:16 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185418/0/en/Visionstate-Reports-Its-First-Profitable-Quarter.htmlVisionstate Reports Its First Profitable Quarter2021-03-02T14:00:00Z2021-03-02T16:58:40ZEDMONTON, Alberta, March 02, 2021 (GLOBE NEWSWIRE) -- Visionstate Corp. (TSX-V: VIS) (“Visionstate” or the “Company”), a company that invests in the research and development of promising new technology in the realm of the Internet of Things, big data and analytics, and sustainability, today announced its first quarterly profit?for the period ended December 31, 2020. ]]>2185418enGlobeNewswire Inc.Visionstate Corp.Tue, 02 Mar 2021 14:02 GMTEarnings Releases and Operating ResultsArtificial IntelligenceCOVID-19Facility managementIoT Internet of ThingsSustainabilityVisionstateWandaSmart buildingshttp://www.yebxqs.cn/news-release/2021/03/02/2185348/0/en/Cellectar-Reports-Financial-Results-for-Year-Ended-December-31-2020-and-Provides-a-Corporate-Update.htmlCellectar Reports Financial Results for Year Ended December 31, 2020 and Provides a Corporate Update2021-03-02T13:30:00Z2021-03-02T16:58:40ZFLORHAM PARK, N.J., March 02, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc.?(NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced financial results for the year ended December 31, 2020 and provided a corporate update.]]>2185348enGlobeNewswire Inc.Cellectar BiosciencesTue, 02 Mar 2021 13:32 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185304/0/en/Kuuhubb-Reports-Fiscal-Q2-2021-Financial-Results.htmlKuuhubb Reports Fiscal Q2 2021 Financial Results2021-03-02T13:16:38Z2021-03-02T16:58:40ZTORONTO, March 02, 2021 (GLOBE NEWSWIRE) -- Kuuhubb Inc. (“Kuuhubb” or the “Company”) (TSX- V: KUU), a mobile game development and publishing company targeting the female audience with bespoke mobile experiences, has reported its unaudited financial results for the three and six months ended December 31, 2020. The Company’s unaudited consolidated financial statements as at, and for the three and six months ended December 31, 2020 and related management’s discussion and analysis can be found on the Company's SEDAR profile at www.sedar.com. The Company’s financial year end is June 30. ]]>2185304enGlobeNewswire Inc.Kuuhubb Inc.Tue, 02 Mar 2021 13:16 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185301/0/en/Partners-Bancorp-Reports-Results-of-Operations-for-the-Fourth-Quarter-2020.htmlPartners Bancorp Reports Results of Operations for the Fourth Quarter 20202021-03-02T13:15:00Z2021-03-02T16:58:40ZSALISBURY, Md., March 02, 2021 (GLOBE NEWSWIRE) -- Partners Bancorp (NASDAQ: PTRS) (the “Company”), the parent company of The Bank of Delmarva (“Delmarva”), Seaford, Delaware, and Virginia Partners Bank (“Virginia Partners”), Fredericksburg, Virginia, reported net income attributable to the Company of $1.1 million, or $0.06 per share, for the three months ended December 31, 2020, a $156 thousand or 16.4% increase when compared to net income attributable to the Company of $950 thousand, or $0.07 per share, for the same period in 2019. For the twelve months ended December 31, 2020, the Company reported net income attributable to the Company of $5.7 million, or $0.32 per share, a $215 thousand or 3.7% decrease when compared to net income attributable to the Company of $5.9 million, or $0.54 per share, for the same period in 2019. The Company’s results of operations for the three and twelve months ended December 31, 2020 were directly impacted by the acquisition of Virginia Partners, whose results of operations were not fully present for the same periods of 2019, and significantly higher provision for credit losses due to the current economic environment and to the COVID-19 pandemic. ]]>2185301enGlobeNewswire Inc.Partners BancorpTue, 02 Mar 2021 13:15 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185294/0/en/Lowell-Farms-Inc-Formerly-Known-as-Indus-Holdings-Inc-Announces-Fourth-Quarter-and-Fiscal-Year-2020-Results.htmlLowell Farms Inc., Formerly Known as Indus Holdings, Inc., Announces Fourth Quarter and Fiscal Year 2020 Results2021-03-02T13:07:53Z2021-03-02T16:58:40ZVertically-Integrated Cannabis Leader Doubles Down on Path to Scalability and Self-Sustaining Profitability With a Renewed Go-Forward Strategy]]>2185294enGlobeNewswire Inc.Indus Holdings, Inc.Tue, 02 Mar 2021 13:08 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185214/0/en/CHF-Solutions-Inc-Announces-49-5-Percent-Increase-in-Revenue-for-Fourth-Quarter-2020-and-Provides-Company-Update.htmlCHF Solutions, Inc. Announces 49.5 Percent Increase in Revenue for Fourth Quarter 2020 and Provides Company Update2021-03-02T13:00:00Z2021-03-02T16:58:40ZEDEN PRAIRIE, Minn., March 02, 2021 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS) announced today its results for the fourth quarter ended December 31, 2020. ]]>2185214enGlobeNewswire Inc.CHF Solutions, Inc.Tue, 02 Mar 2021 13:00 GMTEarnings Releases and Operating ResultsEARNINGSAQUADEXultrafiltrationhttp://www.yebxqs.cn/news-release/2021/03/02/2185254/0/en/Protech-Home-Medical-Reports-Record-First-Quarter-Fiscal-2021-Financial-Results.htmlProtech Home Medical Reports Record First Quarter Fiscal 2021 Financial Results2021-03-02T13:00:00Z2021-03-02T16:58:40ZPosts Revenue Growth of 32% And Adjusted EBITDA Growth of 53%]]>2185254enGlobeNewswire Inc.Protech Home Medical Corp.Tue, 02 Mar 2021 13:02 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185273/0/en/Nanox-Announces-Fourth-Quarter-2020-Results-and-Provides-Business-Update.htmlNanox Announces Fourth Quarter 2020 Results and Provides Business Update2021-03-02T13:00:00Z2021-03-02T16:58:40ZSuccessfully demonstrates the Nanox.ARC in range of 2D and 3D imaging applications at the 2020 Radiology Society of North America (RSNA) Virtual Annual Meeting ]]>2185273enGlobeNewswire Inc.Nano-X Imaging LTD.Tue, 02 Mar 2021 13:04 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185282/0/en/Choom-Announces-Q2-2021-Results-with-350-Year-Over-Year-Growth.htmlChoom Announces Q2 2021 Results with 350% Year Over Year Growth2021-03-02T13:00:00Z2021-03-02T16:58:40ZVANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) -- Choom?Holdings Inc. (“Choom” or the “Company”) (CSE: CHOO; OTCQB: CHOOF), a fast-expanding retail cannabis company is pleased to report its financial and operating results for Q2 2021, ending?December 31, 2020. ]]>2185282enGlobeNewswire Inc.Choom Holdings Inc.?Tue, 02 Mar 2021 13:04 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185159/0/en/Neuronetics-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-and-Operating-Results.htmlNeuronetics Reports Fourth Quarter and Full Year 2020 Financial and Operating Results2021-03-02T12:30:00Z2021-03-02T16:58:40ZMALVERN, Pa., March 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the fourth quarter and full year of 2020.]]>2185159enGlobeNewswire Inc.NeuroneticsTue, 02 Mar 2021 12:30 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185163/0/en/Abercrombie-Fitch-Co-Reports-Fourth-Quarter-and-Full-Year-Results.htmlAbercrombie & Fitch Co. Reports Fourth Quarter and Full Year Results2021-03-02T12:30:00Z2021-03-02T16:58:40ZDelivers fourth quarter net income per diluted share of $1.27 and $1.50 on a GAAP and non-GAAP basis, respectively, fueled by record digital sales, gross profit rate expansion and tight expense controls ]]>2185163enGlobeNewswire Inc.Abercrombie & Fitch Management Co.Tue, 02 Mar 2021 12:30 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185150/0/en/Lithium-Americas-Reports-2020-Full-Year-and-Fourth-Quarter-Results.htmlLithium Americas Reports 2020 Full Year and Fourth Quarter Results2021-03-02T12:26:22Z2021-03-02T16:58:40ZVANCOUVER, British Columbia, March 02, 2021 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) ("Lithium Americas" or the "Company") has reported financial and operating results for the fourth quarter and year ended December 31, 2020. ]]>2185150enGlobeNewswire Inc.Lithium AmericasTue, 02 Mar 2021 12:26 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185078/0/en/Orchard-Therapeutics-Reports-2020-Financial-Results-and-Reviews-Recent-Accomplishments.htmlOrchard Therapeutics Reports 2020 Financial Results and Reviews Recent Accomplishments2021-03-02T12:00:00Z2021-03-02T16:58:40Z$150M Strategic Financing Supports Execution into the First Half of 2023 ]]>2185078enGlobeNewswire Inc.Orchard Therapeutics (Europe) LimitedTue, 02 Mar 2021 12:01 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185085/0/en/TG-Therapeutics-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Year-End-2020-Financial-Results.htmlTG Therapeutics Provides Business Update and Reports Fourth Quarter and Year-End 2020 Financial Results2021-03-02T12:00:00Z2021-03-02T16:58:40ZConference call to be held today, Tuesday, March 2, 2021 at 8:30 AM ET]]>2185085enGlobeNewswire Inc.TG Therapeutics, Inc.Tue, 02 Mar 2021 12:01 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185091/0/en/Antares-Pharma-Reports-Fourth-Quarter-and-Full-Year-2020-Financial-and-Operating-Results.htmlAntares Pharma Reports Fourth Quarter and Full-Year 2020 Financial and Operating Results2021-03-02T12:00:00Z2021-03-02T16:58:40ZFull-Year 2020 Revenue Increases 21% Year-Over-Year to $149.6 Million]]>2185091enGlobeNewswire Inc.Antares Pharma, Inc.Tue, 02 Mar 2021 12:02 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185100/0/en/U-S-Energy-Corp-Provides-Preliminary-Fourth-Quarter-and-Full-Year-2020-Operating-Results-and-2020-Year-End-Proved-Reserves.htmlU.S. Energy Corp. Provides Preliminary Fourth Quarter and Full Year 2020 Operating Results and 2020 Year End Proved Reserves2021-03-02T12:00:00Z2021-03-02T16:58:40ZHOUSTON, March 02, 2021 (GLOBE NEWSWIRE) -- U.S. Energy Corp. (NASDAQCM: USEG) (“U.S. Energy” or the “Company”) today announced operational results for the year and fourth quarter ended December 31, 2020. In addition, the Company announced its estimated proved reserves as of December 31, 2020. ]]>2185100enGlobeNewswire Inc.U.S. Energy Corp.Tue, 02 Mar 2021 12:03 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185126/0/en/Purple-Biotech-Provides-Corporate-Update-and-Reports-Second-Half-and-Full-Year-2020-Financial-Results.htmlPurple Biotech Provides Corporate Update and Reports Second Half and Full Year 2020 Financial Results2021-03-02T12:00:00Z2021-03-02T16:58:40ZRehovot, Israel, March 02, 2021 (GLOBE NEWSWIRE) -- Purple Biotech Ltd. (“Purple Biotech”) (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance, today provided a corporate update and announced financial results for the six and 12-months ended December 31, 2020.]]>2185126enGlobeNewswire Inc.Purple Biotech Ltd. Tue, 02 Mar 2021 12:03 GMTEarnings Releases and Operating ResultsPress releasesCompany Announcementpurplebiotechhttp://www.yebxqs.cn/news-release/2021/03/02/2185127/0/en/RenalytixAI-Reports-Financial-Results-for-Second-Quarter-of-Fiscal-Year-2021.htmlRenalytixAI Reports Financial Results for Second Quarter of Fiscal Year 20212021-03-02T12:00:00Z2021-03-02T16:58:40ZNEW YORK, March 02, 2021 (GLOBE NEWSWIRE) -- Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX) (“RenalytixAI” or the “Company”), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the quarter and six months ended December 31, 2020. ]]>2185127enGlobeNewswire Inc.Renalytix AI plc.Tue, 02 Mar 2021 12:03 GMTEarnings Releases and Operating Resultshttp://www.yebxqs.cn/news-release/2021/03/02/2185057/0/en/AutoZone-2nd-Quarter-Same-Store-Sales-Increase-15-2-EPS-Increases-to-14-93.htmlAutoZone 2nd Quarter Same Store Sales Increase 15.2%;?EPS Increases to $14.932021-03-02T11:55:00Z2021-03-02T16:58:40ZMEMPHIS, Tenn., March 02, 2021 (GLOBE NEWSWIRE) -- AutoZone, Inc. (NYSE: AZO) today reported net sales of $2.9 billion for its second quarter (12 weeks) ended February 13, 2021, an increase of 15.8% from the second quarter of fiscal 2020 (12 weeks). Domestic same store sales, or sales for stores open at least one year, increased 15.2% for the quarter. ]]>2185057enGlobeNewswire Inc.AutoZone, Inc.Tue, 02 Mar 2021 11:55 GMTEarnings Releases and Operating Results粉色午夜视频/色戒未删减版在线观看视频/44383x3全国最大的免费观看/冲田杏梨番号